From the Division of General Internal Medicine, University of Colorado, Aurora, CO (SLC); Colorado Department of Public Health and Environment, Prevention Services Division, Denver, CO (MB, KO); and Ambulatory Care Services, Denver Health and Hospital Authority, Denver, CO (JB).
Received for publication December 29, 2020; Revised May 12, 2021 accepted May 29, 2021.
RxAssurance donated 123 licenses for their PDMP-EHR integration program. Dr. Susan Calcaterra is supported by the National Institute on Drug Abuse (NIDA), National Institutions of Health, grant award number K08DA049905. This work was also supported by the funding Opportunity CE15–1501, entitled Prescription Drug Overdose Prevention for States (Grant #1U17CE002719–01) funded by the Centers for Disease Control and Prevention (CDC).
Dr. Susan Calcaterra is supported by the National Institute on Drug Abuse (NIDA), National Institutions of Health, grant award number K08DA049905. This work was also supported by the funding Opportunity CE15–1501, entitled Prescription Drug Overdose Prevention for States (Grant #1U17CE002719–01) funded by the Centers for Disease Control and Prevention (CDC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, CDC, or the Colorado Department of Public Health and Environment (CDPHE).
The authors report no conflicts of interest.
Study conceptualization and methodology by Blum J, Butler M, Calcaterra SL, and Olson K; Data curation and Investigation by Butler M and Olson K; Formal analysis by Butler M and Calcaterra SL. Funding acquisition, Project administration, Software: NA; Resources: RxAssurance provided free licenses for use of the PDMP-EHR integration program; Roles/Writing - original draft; Calcaterra SL Writing - review & editing; Blum J, Butler M, Calcaterra SL, and Olson K.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.journaladdictionmedicine.com).
Send correspondence to Susan L. Calcaterra, MD, MPH, Division of General Internal Medicine University of Colorado School of Medicine 8th Floor, Academic Office 1 Mailstop B180 12631 E 17th Ave Aurora, CO 80045. E-mail: [email protected]
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.journaladdictionmedicine.com).
